Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Mithra Pharmaceuticals SA
MITRACurrent price
0.22 EUR
-0.004 EUR (-1.82%)
Last closed
0.22 EUR
Company
www.mithra.com
ISIN
BE0974283153
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Euronext Brussels
Capitalization
14 396 942 EUR
Yield for 12 month
-89.49 %
1Y
3Y
5Y
10Y
15Y
MITRA
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium. Address: Rue Saint-Georges 5, Liège, Belgium, 4000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.72 EURP/E ratio
–Dividend Yield
–Current Year
+40 001 425 EUR
Last Year
+66 740 765 EUR
Current Quarter
+32 993 330 EUR
Last Quarter
+7 008 094 EUR
Current Year
+5 968 087 EUR
Last Year
+35 298 481 EUR
Current Quarter
+13 489 210 EUR
Last Quarter
-7 521 124 EUR
Key Figures MITRA
1 year
3 years
5 years
10 years
EBITDA
-52 569 173 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-11.14 %
PEG Ratio
–
Return On Equity TTM
-575.59 %
Wall Street Target Price
0.72 EUR
Revenue TTM
40 001 424 EUR
Book Value
-0.15 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-40.5 %
Dividend Yield
–
Gross Profit TTM
47 192 815 EUR
Earnings per share
-1.4 EUR
Diluted Eps TTM
-1.4 EUR
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MITRA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MITRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MITRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.5113
Enterprise Value Revenue
3.1778
Price Sales TTM
0.3766
Enterprise Value EBITDA
-150.8858
Price Book MRQ
4.5659
Financials MITRA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MITRA
For 52 weeks
0.2 EUR
2.28 EUR
50 Day MA
0.22 EUR
Shares Short Prior Month
–
200 Day MA
0.68 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart